{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:38:04Z","timestamp":1791279484430,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG041718"],"award-info":[{"award-number":["AG041718"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG030653"],"award-info":[{"award-number":["AG030653"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG027224"],"award-info":[{"award-number":["AG027224"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG005133"],"award-info":[{"award-number":["AG005133"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01 AG025204"],"award-info":[{"award-number":["P01 AG025204"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000064","name":"National Center for Complementary and Alternative Medicine","doi-asserted-by":"publisher","award":["U01 AT000162"],"award-info":[{"award-number":["U01 AT000162"]}],"id":[{"id":"10.13039\/100000064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neurobiolaging.2015.04.012","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T23:20:52Z","timestamp":1430004052000},"page":"2443.e21-2443.e26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk"],"prefix":"10.1016","volume":"36","author":[{"given":"Samantha L.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhil N.","family":"Bamne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Snitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Yesim","family":"Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar L.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ilyas","family":"Kamboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib1","unstructured":"Alzheimers Association. [Internet]. Chicago: c2015. [accessed 12 Jan 2015]. Alzheimer's Facts and Figures: Quick Facts. Available from: http:\/\/www.alz.org\/alzheimers_disease_facts_and_figures.asp#quickFacts."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib50","doi-asserted-by":"crossref","first-page":"1779.e15","DOI":"10.1016\/j.neurobiolaging.2014.01.020","article-title":"Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of lateonset Alzheimer's disease","volume":"35","author":"Bamne","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib2","doi-asserted-by":"crossref","first-page":"1711.e15","DOI":"10.1016\/j.neurobiolaging.2012.12.018","article-title":"TREM2 is associated with the risk of Alzheimer's disease in Spanish population","volume":"34","author":"Benitez","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuron.2013.02.026","article-title":"GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease","volume":"78","author":"Cruchaga","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib5","doi-asserted-by":"crossref","first-page":"726.e11","DOI":"10.1016\/j.neurobiolaging.2013.09.009","article-title":"Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia","volume":"35","author":"Cuyvers","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib6","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1001\/jama.2008.683","article-title":"Ginkgo biloba for prevention of dementia: a randomized controlled trial","volume":"300","author":"DeKosky","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib7","doi-asserted-by":"crossref","first-page":"555.e9","DOI":"10.1016\/j.neurobiolaging.2010.10.003","article-title":"No association of psychosis in Alzheimer disease with neurodegenerative pathway genes","volume":"32","author":"DeMichele-Sweet","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib9","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.neurobiolaging.2013.11.013","article-title":"Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention","volume":"35","author":"Engelman","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib10","doi-asserted-by":"crossref","first-page":"546.e9","DOI":"10.1016\/j.neurobiolaging.2014.08.001","article-title":"TREM2 analysis and increased risk of Alzheimer's disease","volume":"36","author":"Finelli","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib12","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib13","doi-asserted-by":"crossref","first-page":"2077.e11","DOI":"10.1016\/j.neurobiolaging.2013.02.016","article-title":"Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease","volume":"34","author":"Giraldo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib14","doi-asserted-by":"crossref","first-page":"2889.e11","DOI":"10.1016\/j.neurobiolaging.2013.06.004","article-title":"Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study","volume":"34","author":"Gonzalez Murcia","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib15","first-page":"117","article-title":"TREM2 variants in Alzheimer\u2019s disease. N. Engl","volume":"368","author":"Guerreiro","year":"2013","journal-title":"J. Med"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib17","doi-asserted-by":"crossref","first-page":"2890.e1","DOI":"10.1016\/j.neurobiolaging.2013.06.005","article-title":"Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family","volume":"34","author":"Guerreiro","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib20","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1532-5415.2006.00854.x","article-title":"Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease","volume":"54","author":"Hollingworth","year":"2006","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1212\/WNL.0000000000000855","article-title":"The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk","volume":"83","author":"Hooli","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A\u00a0role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.neurobiolaging.2013.11.026","article-title":"Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice","volume":"35","author":"Jiang","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib49","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","article-title":"Coding variants in TREM2 increase risk for Alzheimer's disease","volume":"23","author":"Jin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A\u00a0mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib26","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/tp.2012.45","article-title":"Genome-wide association study of Alzheimer's disease","volume":"2","author":"Kamboh","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib27","doi-asserted-by":"crossref","first-page":"1518.e1","DOI":"10.1016\/j.neurobiolaging.2012.09.017","article-title":"Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population","volume":"34","author":"Kero","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib28","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib30","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib31","article-title":"Neuroinflammation in Alzheimer's disease; a source of heterogeneity and target for personalized therapy","author":"Latta","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib32","article-title":"TYROBP in Alzheimer's disease","author":"Ma","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3233\/JAD-140225","article-title":"Lack of genetic association between TREM2 and late-onset Alzheimer's disease in a Japanese population","volume":"41","author":"Miyashita","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biopsych.2013.08.020","article-title":"Psychosis in Alzheimer's disease","volume":"75","author":"Murray","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib35","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.neurobiolaging.2012.02.015","article-title":"\u03b2-Amyloid 42\/40 ratio and kalirin expression in Alzheimer disease with psychosis","volume":"33","author":"Murray","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-122311","article-title":"TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease","volume":"35","author":"Pottier","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib40","article-title":"The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia","author":"Roussos","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib41","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","article-title":"Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia","volume":"83","author":"Schmid","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib42","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib43","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp.74.6.825-a","article-title":"An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene","volume":"74","author":"Soragna","year":"2003","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","article-title":"R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia","volume":"10","author":"Slattery","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib45","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/awq001","article-title":"Assessment and familial aggregation of psychosis in Alzheimer's disease from the National Institute on Aging Late Onset Alzheimer's Disease Family Study","volume":"133","author":"Sweet","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib46","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.152.9.1349","article-title":"The behavior rating scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease","volume":"152","author":"Tariot","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/ajmg.b.30549","article-title":"Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism","volume":"144B","author":"Wilkosz","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2015.04.012_bib48","doi-asserted-by":"crossref","first-page":"937.e1","DOI":"10.1016\/j.neurobiolaging.2013.10.075","article-title":"Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer's disease in Han Chinese individuals","volume":"35","author":"Yu","year":"2014","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015002341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015002341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T23:55:23Z","timestamp":1566604523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0197458015002341"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.012","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}